Skip to main content
. Author manuscript; available in PMC: 2008 Nov 25.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2008 Sep;4(9):1223–1234. doi: 10.1517/17425255.4.9.1223

Table 3. Comparison of riluzole and lamotrigine.

Riluzole Lamotrigine
Neuroprotective Yes Yes
Anticonvulsant Yes Yes
Efficacy in acute MDD Yes (only open-label studies) ? Yes (the majority of controlled studies are not positive; clear evidence in maintenance treatment)
Inhibition of voltage-gated Na+ channels Yes Yes
Ca2+ channel blockade Yes (P/Q type) Yes (N- and P-type)
AMPA potentiator Yes Yes
Increased expression of BDNF Yes ??
Dose titration None or rapid Very slow
Steven-Johnson’s syndrome No Yes
Response to the other agent 3 out of 4 lamotrigine responders responded to riluzole ?